Echo- and B-Type Natriuretic Peptide-Guided Follow-Up versus Symptom-Guided Follow-Up: Comparison of the Outcome in Ambulatory Heart Failure Patients

<div>Frequencies of patients with an E-wave deceleration time (EDT) &lt; 150 ms, a ratio of E/averaged myocardial early velocity (averaged <i>E</i>/<i>e</i>′) ≥ 13, and presence of ≥15 B-lines at lung ultrasound. Comparison between baseline (dark gray bar) and follow-up (light gray bar).</div>

Cardiology Research and Practice

fig2

Figure 2

Figure 2: Echo- and B-Type Natriuretic Peptide-Guided Follow-Up versus Symptom-Guided Follow-Up: Comparison of the Outcome in Ambulatory Heart Failure Patients 

Figure 2 | Echo- and B-Type Natriuretic Peptide-Guided Follow-Up versus Symptom-Guided Follow-Up: Comparison of the Outcome in Ambulatory Heart Failure Patients 